Literature DB >> 6641234

Interaction between prognostic factors and treatment.

J Shuster, J van Eys.   

Abstract

In randomized trials, the better therapy may depend on values of a prognostic factor. This article presents methodology for subdividing a target population into three subsets: one region of superiority of each treatment, and one region of uncertainty. The basis of such a subdivision is treatment by prognostic factor interaction. The importance of this analysis in group trial sequences is discussed briefly.

Mesh:

Year:  1983        PMID: 6641234     DOI: 10.1016/0197-2456(83)90004-1

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  10 in total

1.  Detecting moderator effects using subgroup analyses.

Authors:  Rui Wang; James H Ware
Journal:  Prev Sci       Date:  2013-04

2.  Estimation of treatment policies based on functional predictors.

Authors:  Ian W McKeague; Min Qian
Journal:  Stat Sin       Date:  2014-07       Impact factor: 1.261

3.  Variable Selection for Qualitative Interactions.

Authors:  L Gunter; J Zhu; S A Murphy
Journal:  Stat Methodol       Date:  2011-01-30

4.  Detecting treatment-covariate interactions using permutation methods.

Authors:  Rui Wang; David A Schoenfeld; Bettina Hoeppner; A Eden Evins
Journal:  Stat Med       Date:  2015-03-02       Impact factor: 2.373

5.  Variable selection for qualitative interactions in personalized medicine while controlling the family-wise error rate.

Authors:  Lacey Gunter; Ji Zhu; Susan Murphy
Journal:  J Biopharm Stat       Date:  2011-11       Impact factor: 1.051

6.  Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy.

Authors:  Pamela A Frischmeyer-Guerrerio; Madhan Masilamani; Wenjuan Gu; Erica Brittain; Robert Wood; Jennifer Kim; Kari Nadeau; Kirsi M Jarvinen; Alexander Grishin; Robert Lindblad; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2017-04-13       Impact factor: 10.793

7.  Discordant minimum inhibitory concentration analysis: a new path to licensure for anti-infective drugs.

Authors:  Dean Follmann; Erica Brittain; John H Powers
Journal:  Clin Trials       Date:  2013       Impact factor: 2.486

8.  An approach to evaluating and comparing biomarkers for patient treatment selection.

Authors:  Holly Janes; Marshall D Brown; Ying Huang; Margaret S Pepe
Journal:  Int J Biostat       Date:  2014       Impact factor: 0.968

9.  Evaluating the Effectiveness of Personalized Medicine With Software.

Authors:  Adam Kapelner; Justin Bleich; Alina Levine; Zachary D Cohen; Robert J DeRubeis; Richard Berk
Journal:  Front Big Data       Date:  2021-05-18

10.  Quint: An R package for the identification of subgroups of clients who differ in which treatment alternative is best for them.

Authors:  Elise Dusseldorp; Lisa Doove; Iven van Mechelen
Journal:  Behav Res Methods       Date:  2016-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.